SUBCUTANEOUS BORTEZOMIB CONTAINING REGIMENS AS UPFRONT TREATMENT OF NEWLY DIAGNOSED TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS I. Rizzello,E. Zamagni, L. Dozza,M. Quaresima,M. T. Petrucci,V. De Stefano,E. Antonioli,P. Tosi,M. D'Agostino,M. Offidani,A. Gozzetti, G. Rivoli,N. Testoni,M. Martello, P. Tacchetti,L. Pantani,K. Mancuso,S. Rocchi, I. Caratozzolo,M. CavoHAEMATOLOGICA(2019)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要